Coeptis Therapeutics (COEP) Revenue & Revenue Breakdown
Coeptis Therapeutics Revenue Highlights
0
Latest Revenue (Q)
$62.87K
Coeptis Therapeutics Revenue by Period
Coeptis Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | -100.00% |
| 2021-12-31 | $75.00K | 143.82% |
| 2020-12-31 | $30.76K | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2005-12-31 | - | 100.00% |
| 2004-12-31 | - | - |
Coeptis Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Coeptis Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $62.87K | -96.63% |
| 2024-12-31 | $1.86M | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $1.50M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2021-09-30 | $9.89K | 100.00% |
| 2021-06-30 | - | -100.00% |
| 2021-03-31 | $75.00K | 100.00% |
| 2020-11-30 | - | 100.00% |
| 2020-08-31 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2005-12-31 | - | 100.00% |
| 2005-09-30 | - | 100.00% |
| 2005-06-30 | - | 100.00% |
| 2005-03-31 | - | 100.00% |
| 2004-12-31 | - | 100.00% |
| 2004-09-30 | - | - |
Coeptis Therapeutics generated $62.87K in revenue during Q1 2025, up -96.63% compared to the previous quarter, and up 4.19% compared to the same period a year ago.
Coeptis Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics | $145.24M | $44.04M |
| EQ | Equillium | $41.09M | - |
| IPSC | Century Therapeutics | $6.59M | $109.16M |
| CUE | Cue Biopharma | $5.49M | $2.95M |
| COEP | Coeptis Therapeutics | - | $62.87K |
| OSTX | OS Therapies | - | - |
| OTLK | Outlook Therapeutics | - | - |
| MDCX | Medicus Pharma | - | - |
| TELO | Telomir Pharmaceuticals | - | - |
| NRXP | NRx Pharmaceuticals | - | - |
| SNTI | Senti Biosciences | - | - |